Itraconazole Sandoz

Itraconazole, the active ingredient in Itraconazole Sandoz, is an azole antifungal presented as an oral dosage form for oral use. It treats systemic fungal infections such as blastomycosis, histoplasmosis, aspergillosis, candidiasis, and dermatophyte infections in adult patients. The drug is absorbed systemically and distributes to tissues where fungi reside, providing therapeutic concentrations.

GNH USA supplies Itraconazole Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our global network ensures reliable sourcing, regulatory compliance, and timely delivery to meet the needs of healthcare providers across multiple regions.

Itraconazole is used to treat systemic fungal infections by targeting a broad range of pathogenic fungi.

- Blastomycosis: effective therapy to eradicate Blastomyces dermatitidis infection. - Histoplasmosis: clears Histoplasma capsulatum from affected organs. - Aspergillosis: controls invasive disease caused by Aspergillus species. - Candidiasis: treats severe or disseminated Candida infections. - Dermatophyte infections: resolves deep or extensive skin fungal infections.

Common adverse reactions are generally mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Diarrhea: loose stools occurring during therapy. - Elevated liver enzymes: mild increase in hepatic transaminases.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury requiring monitoring. - Congestive heart failure: fluid retention and reduced cardiac function. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures.

- Liver function: assess baseline hepatic enzymes and monitor periodically. - Cardiac status: avoid in patients with existing congestive heart failure. - Drug interactions: review concomitant medications for potential CYP3A4 interactions. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Itraconazole has a notable interaction profile that requires careful management.

Major Interactions (Avoid): - Rifampicin: strong inducer of CYP3A4, markedly reduces itraconazole exposure. - St. John’s wort: herbal CYP3A4 inducer, decreases antifungal efficacy. - Certain antiretrovirals (e.g., efavirenz): may lower itraconazole levels.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin): increased risk of myopathy; consider dose adjustment. - Calcium channel blockers (e.g., verapamil): may raise itraconazole concentrations, monitor for toxicity.